Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pitts

Showing results (181-190 of 231) with videos related to

Pageof 24
Sort By:
Prostaglandins & Other Lipid Mediators|August 11, 2000
PPARgamma: observations in the hematopoietic systemM E Greene, J Pitts, M A McCarville, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 1999
Rapid synthesis of RGD mimetics with isoxazoline scaffolds on solid phase: identification of alphavbeta3 antagonists lead compoundsA L Rockwell, M Rafalski, W J Pitts, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Phosphodiesterase 7A-deficient mice have functional T cellsGuchen Yang, Kim W McIntyre, Robert M Townsend, et al.
Organic Letters|June 7, 2002
A modified approach to 2-(N-aryl)-1,3-oxazoles: application to the synthesis of the IMPDH inhibitor BMS-337197 and analoguesT G Murali Dhar, Junqing Guo, Zhongqi Shen, et al.
Protein Engineering|November 1, 1996
Engineering the C-region of human insulin-like growth factor-1: implications for receptor bindingR Gill, B Wallach, C Verma, et al.
Genetics|March 10, 2001
Genomic organization and characterization of the white locus of the Mediterranean fruitfly, Ceratitis capitataL M Gomulski, R J Pitts, S Costa, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2009
Identification of potent pyrimidine inhibitors of phosphodiesterase 7 (PDE7) and their ability to inhibit T cell proliferationJunqing Guo, Andrew Watson, James Kempson, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|January 31, 2018
Advancing pharmaceuticals and patient safety in Saudi Arabia: A 2030 vision initiativeTariq M Alhawassi, Hatem A Abuelizz, Mansour Almetwazi, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2005
Fused pyrimidine based inhibitors of phosphodiesterase 7 (PDE7): synthesis and initial structure-activity relationshipsJames Kempson, William J Pitts, Joseph Barbosa, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2017
Discovery and structure-based design of 4,6-diaminonicotinamides as potent and selective IRAK4 inhibitorsRajeev S Bhide, Alec Keon, Carolyn Weigelt, et al.
Pageof 24

Showing results (181-190 of 231) with videos related to

Sort By:
Pageof 24
Prostaglandins & Other Lipid Mediators|August 11, 2000
PPARgamma: observations in the hematopoietic systemM E Greene, J Pitts, M A McCarville, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 1999
Rapid synthesis of RGD mimetics with isoxazoline scaffolds on solid phase: identification of alphavbeta3 antagonists lead compoundsA L Rockwell, M Rafalski, W J Pitts, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Phosphodiesterase 7A-deficient mice have functional T cellsGuchen Yang, Kim W McIntyre, Robert M Townsend, et al.
Organic Letters|June 7, 2002
A modified approach to 2-(N-aryl)-1,3-oxazoles: application to the synthesis of the IMPDH inhibitor BMS-337197 and analoguesT G Murali Dhar, Junqing Guo, Zhongqi Shen, et al.
Protein Engineering|November 1, 1996
Engineering the C-region of human insulin-like growth factor-1: implications for receptor bindingR Gill, B Wallach, C Verma, et al.
Genetics|March 10, 2001
Genomic organization and characterization of the white locus of the Mediterranean fruitfly, Ceratitis capitataL M Gomulski, R J Pitts, S Costa, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2009
Identification of potent pyrimidine inhibitors of phosphodiesterase 7 (PDE7) and their ability to inhibit T cell proliferationJunqing Guo, Andrew Watson, James Kempson, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|January 31, 2018
Advancing pharmaceuticals and patient safety in Saudi Arabia: A 2030 vision initiativeTariq M Alhawassi, Hatem A Abuelizz, Mansour Almetwazi, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2005
Fused pyrimidine based inhibitors of phosphodiesterase 7 (PDE7): synthesis and initial structure-activity relationshipsJames Kempson, William J Pitts, Joseph Barbosa, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2017
Discovery and structure-based design of 4,6-diaminonicotinamides as potent and selective IRAK4 inhibitorsRajeev S Bhide, Alec Keon, Carolyn Weigelt, et al.
Pageof 24